Deciphering the role of ectosomes in cancer development and progression: focus on the proteome

Clinical and Experimental Metastasis

Volumn 34, Issue 3-4, 2017, Pages 273-289

  Surman, Magdalena ^a   Stępień, Ewa ^a   Hoja Łukowicz, Dorota ^a   Przybyło, Małgorzata ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Cancer; Ectosomes; Immunosuppression; Intracellular communication; Multidrug resistance; Tumor microenvironment

Indexed keywords

PROTEOME;

ANGIOGENESIS; CANCER GROWTH; CARCINOGENESIS; CELL COMMUNICATION; CELL CONTACT; CELL FUNCTION; CELL GROWTH; CELL INVASION; CELL SURVIVAL; ECTOSOME; ENDOPLASMIC RETICULUM; EXOSOME; EXTRACELLULAR SPACE; GLIOBLASTOMA CELL LINE; GLIOMA CELL; HUMAN; INTERCELLULAR SPACE; MEMBRANE VESICLE; NONHUMAN; REVIEW; RNA PROCESSING; TARGET CELL; ANIMAL; CELL TRANSFORMATION; DISEASE COURSE; MEMBRANE MICROPARTICLE; NEOPLASM; PATHOLOGY;

ANIMALS; CELL COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; CELL-DERIVED MICROPARTICLES; DISEASE PROGRESSION; HUMANS; NEOPLASMS;

EID: 85015619730     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-017-9844-z     Document Type: Review

References (110)

1. Minciacchi VR, Freeman MR, Di Vizio D (2015) Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol 40:41–51. doi:10.1016/j.semcdb.2015.02.010
2. Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200:373–383. doi:10.1083/jcb.201211138
3. Mause SF, Weber C (2010) Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 107:1047–1057.doi: 10.1161/CIRCRESAHA.110.226456
4. Hargett LA, Bauer NN (2013) On the origin of microparticles: from “platelet dust” to mediators of intercellular communication. Pulm Circ 3:329–340. doi:10.4103/2045-8932.114760
5. Van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R (2012) Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 64:676–705. doi:10.1124/pr.112.005983
6. Rak J (2010) Microparticles in cancer. Semin Thromb Hemost 36:888–906. doi:10.1055/s-0030-1267043
7. Cocucci E, Meldolesi J (2015) Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol 25:364–372. doi:10.1016/j.tcb.2015.01.004
8. Gong J, Jaiswal R, Dalla P, Luk F, Bebawy M (2015) Microparticles in cancer: a review of recent developments and the potential for clinical application. Semin Cell Dev Biol 40:35–40. doi:10.1016/j.semcdb.2015.03.009
9. Junquera C, Castiella T, Muńoz G, Fernandez-Pacheco R, Luesma MJ, Monzón M (2016) Biogenesis of a new type of extracellular vesicles in gastrointestinal stromal tumors: ultrastructural profiles of spheresomes. Histochem Cell Biol 146:557–567. doi:10.1007/s00418-016-1460-5
10. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ (2005) Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113:752–760. doi:10.1002/ijc.20657
11. Mezouar S, Mege D, Darbousset R, Farge D, Debourdeau P, Dignat-George F, Panicot-Dubois L, Dubois C (2014) Involvement of platelet-derived microparticles in tumor progression and thrombosis. Semin Oncol 41:346–358. doi:10.1053/j.seminoncol.2014.04.010
12. Dolo V, Ginestra A, Cassarŕ D, Violini S, Lucania G, Torrisi MR, Nagase H, Canevari S, Pavan A, Vittorelli ML (1998) Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res 58:4468–4474
13. Stec M, Baj-Krzyworzeka M, Baran J, Węglarczyk K, Zembala M, Barbasz J, Szczepanik A, Zembala M (2015) Isolation and characterization of circulating micro(nano)vesicles in the plasma of colorectal cancer patients and their interactions with tumor cells. Oncol Rep 34:2768–2775. doi:10.3892/or.2015.4228
14. Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G, D’Souza-Schorey C (2009) ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol 19:1875–1885. doi:10.1016/j.cub.2009.09.059
15. D’Souza-Schorey C, Chavrier P (2006) ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 7:347–358. doi:10.1038/nrm1910
16. Tesselaar ME, Romijn FP, Van der Linden IK, Prins FA, Bertina RM, Osanto S (2007) Microparticle-associated tissue factor activity: a link between cancer and thrombosis. J Thromb Haemost 5:520–527. doi:10.1111/j.1538-7836.2007.02369.x
17. Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, Rak J (2008) Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 10:619–624. doi:10.1038/ncb1725
18. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J (2009) Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 106:3794–3799. doi:10.1073/pnas.0804543106
19. Berchem G, Noman MZ, Bosseler M, Paggetti J, Baconnais S, Le Cam E, Nanbakhsh A, Moussay E, Mami-Chouaib F, Janji B, Chouaib S (2015) Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-β and miR23a transfer. Oncoimmunology. doi:10.1080/2162402X.2015.1062968
20. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA (2005) Tissue factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106:1604–1611. doi:10.1182/blood-2004-03-1095
21. Shi J, Heegaard CW, Rasmussen JT, Gilbert GE (2004) Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature. Biochim Biophys Acta 1667:82–90. doi:10.1016/j.bbamem.2004.09.006
22. Kim CW, Lee HM, Lee TH, Kang C, Kleinman HK, Gho YS (2002) Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res 62:6312–6317
23. Dolo V, D’Ascenzo S, Violini S, Pompucci L, Festuccia C, Ginestra A, Vittorelli ML, Canevari S, Pavan A (1999) Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin Exp Metastasis 17:131–140
24. Castellana D, Zobairi F, Martinez MC, Panaro MA, Mitolo V, Freyssinet JM, Kunzelmann C (2009) Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res 69:785–793. doi:10.1158/0008-5472.CAN-08-1946
25. Angelucci A, D’Ascenzo S, Festuccia C, Gravina GL, Bologna M, Dolo V, Pavan A (2000) Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines. Clin Exp Metast 18:163–170. doi:10.1023/A:1006778000173
26. Wysoczynski M, Ratajczak MZ (2009) Lung cancer secreted microvesicles: underappreciated modulators of microenvironment in expanding tumors. Int J Cancer 125:1595–1603. doi:10.1002/ijc.24479
27. Millimaggi D, Mari M, D’Ascenzo S, Carosa E, Jannini EA, Zucker S, Carta G, Pavan A, Dolo V (2007) Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia 9:349–357. doi:10.1593/neo.07133
28. Taraboletti G, D’Ascenzo S, Giusti I, Marchetti D, Borsotti P, Millimaggi D, Giavazzi R, Pavan A, Dolo V (2006) Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia 8:96–103. doi:10.1593/neo.05583
29. Bianco F, Perrotta C, Novellino L, Francolini M, Riganti L, Menna E, Saglietti L, Schuchman EH, Furlan R, Clementi E, Matteoli M, Verderio C (2009) Acid sphingomyelinaseactivity triggers microparticle release from glial cells. EMBO J 28:1043–1054. doi:10.1038/emboj.2009.45
30. Charras GT, Yarrow JC, Horton MA, Mahadevan L, Mitchison TJ (2005) Non-equilibration of hydrostatic pressure in blebbing cells. Nature 435:365–369. doi:10.1038/nature03550
31. Jaiswal R, Luk F, Dalla PV, Grau GE, Bebawy M (2013) Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cells. PLoS ONE. doi:10.1371/journal.pone.0061515
32. Pokharel D, Padula MP, Lu JF, Tacchi JL, Luk F, Djordjevic SP, Bebawy M (2014) Proteome analysis of multidrug-resistant, breast cancer-derived microparticles. J Extracell Vesicles 3:1–10. doi:10.3402/jev.v3.24384
33. Choi DS, Kim DK, Kim YK, Gho YS (2015) Proteomics of extracellular vesicles: exosomes and ectosomes. Mass Spectrom Rev 34:474–490. doi:10.1002/mas.21420
34. Stępień E, Kabłak-Ziembicka A, Czyż J, Przewłocki T, Małecki M (2012) Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging. Expert Opin Ther Targets 16:677–688. doi:10.1517/14728222.2012.691471
35. Alexandru N, Badila E, Weiss E, Cochior D, Stępień E, Georgescu A (2016) Vascular complications in diabetes: Microparticles and microparticle associated microRNAs as active players. Biochem Biophys Res Commun 472:1–10. doi:10.1016/j.bbrc.2016.02.038
36. Muralidharan-Chari V, Clancy JW, Sedgwick A, D’Souza-Schorey C (2010) Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123:1603–1611. doi:10.1242/jcs.064386
37. Li B, Antonyak MA, Zhang J, Cerione RA (2012) RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. Oncogene 31:4740–4749. doi:10.1038/onc.2011.636
38. Wolf P (1967) The nature and significance of platelet products in human plasma. Br J Haematol 13:269–288. doi:10.1111/j.1365-2141.1967.tb08741.x
39. Morel O, Jesel L, Freyssinet JM, Toti F (2011) Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 31:15–26. doi:10.1161/ATVBAHA.109.200956
40. Pap E, Pállinger E, Pásztói M, Falus A (2009) Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res 58:1–8. doi:10.1007/s00011-008-8210-7
41. Solari FA, Mattheij NJ, Burkhart JM, Swieringa F, Collins PW, Cosemans JM, Sickmann A, Heemskerk JW, Zahedi RP (2016) Combined quantification of the global proteome, phosphoproteome and proteolytic cleavage to characterize altered platelet functions in the human Scott syndrome. Mol Cell Proteom 15:3154–3169. doi:10.1074/mcp.M116.060368
42. Otzen DE, Blans K, Wang H, Gilbert GE, Rasmussen JT (2012) Lactadherin binds to phosphatidylserine-containing vesicles in a two-step mechanism sensitive to vesicle size and composition. Biochim Biophys Acta 1818:1019–1027. doi:10.1016/j.bbamem.2011.08.032
43. Friend C, Marovitz W, Henie G, Henie W, Tsuei D, Hirschhorn K, Holland JG, Cuttner J (1978) Observations on cell lines derived from a patient with Hodgkin’s disease. Cancer Res 38:2581–2591
44. Poste G, Nicolson GL (1980) Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci USA 77:399–403
45. Poutsiaka DD, Schroder EW, Taylor DD, Levy EM, Black PH (1985) Membrane vesicles shed by murine melanoma cells selectively inhibit the expression of Ia antigen by macrophages. J Immunol 134:138–144
46. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ (2006) Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20:1487–1495. doi:10.1038/sj.leu.2404296
47. Antonyak MA, Li B, Boroughs LK, Johnson JL, Druso JE, Bryant KL, Holowka DA, Cerione RA (2011) Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci USA 108:4852–4857. doi:10.1073/pnas.1017667108
48. Skog J, Würdinger T, Van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry MT Jr, Carter BS, Krichevsky AM, Breakefield XO (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470–1476. doi:10.1038/ncb1800
49. Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL (2010) Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS ONE. doi:10.1371/journal.pone.0011469
50. Ogorevc E, Kralj-Iglic V, Veranic P (2013) The role of extracellular vesicles in phenotypic cancer transformation. Radiol Oncol 47:197–205. doi:10.2478/raon-2013-0037
51. Ginestra A, Monea S, Seghezzi G, Dolo V, Nagase H, Mignatti P, Vittorelli ML (1997) Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J Biol Chem 272:17216–17222. doi:10.1074/jbc.272.27.17216
52. Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, Winberg JO (2010) Regulation of matrix metalloproteinase activity in health and disease. FEBS J 278:28–45. doi:10.1111/j.1742-4658.2010.07920.x
53. Giusti I, D’Ascenzo S, Millimaggi S, Taraboletti G, Carta G, Franceschini N, Pavan A, Dolo V (2008) Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles. Neoplasia 10:481–488. doi:10.1593/neo.08178
54. Lo Cicero A, Majkowska I, Nagase H, Di Liegro I, Troeberg L (2012) Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity. Matrix Biol 31:229–233. doi:10.1016/j.matbio.2012.02.005
55. Lindoso RS, Collino F, Camussi G (2015) Extracellular vesicles derived from renal cancer stem cells induce a pro-tumorigenic phenotype in mesenchymal stromal cells. Oncotarget 6:7959–7969. doi:10.18632/oncotarget.3503
56. Bordeleau F, Chan B, Antonyak MA, Lampi MC, Cerione RA, Reinhart-King CA (2016) Microvesicles released from tumor cells disrupt epithelial cell morphology and contractility. J Biomech 49:1272–1279. doi:10.1016/j.jbiomech.2015.10.003
57. Schroder WA, Major LD, Le TT, Gardner J, Sweet MJ, Janciauskiene S, Suhrbier A (2014) Tumor cell-expressed SerpinB2 is present on microparticles and inhibits metastasis. Cancer Med 3:500–513. doi:10.1002/cam4.229
58. Liu Y, Zhu XJ, Zeng C, Wu PH, Wang HX, Chen ZC, Li QB (2014) Microvesicles secreted from human multiple myeloma cells promote angiogenesis. Acta Pharmacol Sin 35:230–238. doi:10.1038/aps.2013
59. Munster M, Fremder E, Miller V, Ben-Tsedek N, Davidi S, Scherer SJ, Shaked Y (2014) Anti-VEGF-A affects the angiogenic properties of tumor-derived microparticles. PLoS ONE. doi:10.1371/journal.pone.0095983
60. Kovacic JC, Mercader N, Torres M, Boehm M, Fuster V (2012) Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease. Circulation 125:1795–1808. doi:10.1161/CIRCULATIONAHA.111.040352
61. Bobis-Wozowicz S, Kmiotek K, Kania K, Karnas E, Labedz-Maslowska A, Sekula M, Kedracka-Krok S, Kolcz J, Boruczkowski D, Madeja Z, Zuba-Surma EK (2016) Diverse impact of xeno-free conditions on biological and regenerative properties of hUC-MSCs and their extracellular vesicles. J Mol Med. doi:10.1007/s00109-016-1471-7
62. Zhang H, Bai M, Deng T, Liu R, Wang X, Qu Y, Duan J, Zhang L, Ning T, Ge S, Li H Zhou L, Liu Y, Huang D, Ying G, Ba Y (2016) Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma. Cancer Lett 375:331–339. doi:10.1016/j.canlet.2016.03.026
63. Yamada N, Tsujimura N, Kumazaki M, Shinohara H, Taniguchi K, Nakagawa Y, Naoe T, Akao Y (2014) Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells. Biochim Biophys Acta 1839:1256–1272. doi:10.1016/j.bbagrm.2014.09.002
64. Goubran H, Sabry W, Kotb R, Seghatchian J, Burnouf T (2015) Platelet microparticles and cancer: an intimate cross-talk. Transfus Apher Sci 53:168–172. doi:10.1016/j.transci.2015.10.014
65. Esumi N, Todo S, Imashuku S (1987) Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line. Cancer Res 47:2129–2135
66. Trummer A, De Rop S, Stadler M, Ganser A, Buchholz S (2011) P-selectin glycoprotein ligand-1 positive microparticles in allogeneic stem cell transplantation of hematologic malignancies. Exp Hematol 39:1047–1055. doi:10.1016/j.exphem.2011.08.007
67. Vandendries ER, Furie BC, Furie B (2004) Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost 92:459–466. doi:10.1160/TH04-05-0306
68. Mackman N, Luther T (2013) Platelet tissue factor: to be or not to be. Thromb Res 132:3–5. doi:10.1016/j.thromres.2013.05.009
69. Gardiner C, Harrison P, Belting M, Böing A, Campello E, Carter BS, Collier ME, Coumans F, Ettelaie C, Van Es N, Hochberg FH, Mackman N, Rennert RC, Thaler J, Rak J, Nieuwland R (2015) Extracellular vesicles, tissue factor, cancer and thrombosis—discussion themes of the ISEV 2014 Educational Day. J Extracell Vesicles. doi:10.3402/jev.v4.26901
70. Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI, Coomber BL, Mackman N, Rak JW (2005) Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105:1734–1741. doi:10.1182/blood-2004-05-2042
71. Lima LG, Leal AC, Vargas G, Porto-Carreiro I, Monteiro RQ (2013) Intercellular transfer of tissue factor via the uptake of tumor-derived microvesicles. Thromb Res 132:450–456. doi:10.1016/j.thromres.2013.07.026
72. Hron G, Kollars M, Weber H, Sagaster V, Quehen-Berger P, Eichinger S, Kyrle PA, Weltermann A (2007) Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 97:119–123. doi:10.1160/TH06-03-0141
73. Mezouar S, Darbousset R, Dignat-George F, Panicot-Dubois L, Dubois C (2015) Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo. Int J Cancer 136:462–475. doi:10.1002/ijc.28997
74. Baj-Krzyworzeka M, Weglarczyk K, Mytar B, Szatanek R, Baran J, Zembala M (2011) Tumour-derived microvesicles contain interleukin-8 and modulate production of chemokines by human monocytes. Anticancer Res 31:1329–1335
75. Köppler B, Cohen C, Schlöndorff D, Mack M (2006) Differential mechanisms of microparticle transfer to B cells and monocytes: anti-inflammatory properties of microparticles. Eur J Immunol 36:648–660. doi:10.1002/eji.200535435
76. Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, Corbelli A, Fais S, Parmiani G, Rivoltini L (2006) Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res 66:9290–9298. doi:10.1158/0008-5472.CAN-06-1819
77. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Zembala M (2007) Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol Lett 113:76–82. doi:10.1016/j.imlet.2007.07.014
78. Baj-Krzyworzeka M, Mytar B, Szatanek R, Surmiak M, Węglarczyk K, Baran J, Siedlar M (2016) Colorectal cancer-derived microvesicles modulate differentiation of human monocytes to macrophages. J Transl Med 14:1–15. doi:10.1186/s12967-016-0789-9
79. Kuang DM, Wu Y, Chen N, Cheng J, Zhuang SM, Zheng L (2007) Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 110:587–595. doi:10.1182/blood-2007-01-068031
80. Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles: artefacts no more. Trends Cell Biol 19:43–51. doi:10.1016/j.tcb.2008.11.003
81. Sadallah S, Eken C, Schifferli JA (2011) Ectosomes as modulators of inflammation and immunity. Clin Exp Immunol 163:26–32. doi:10.1111/j.1365-2249.2010.04271.x
82. Ma J, Cai W, Zhang Y, Huang C, Zhang H, Liu J, Tang K, Xu P, Katirai F, Zhang J, He W, Ye D, Shen GX, Huang B (2013) Innate immune cell-derived microparticles facilitate hepatocarcinoma metastasis by transferring integrin α(M)β2 to tumor cells. J Immunol 191:3453–3461. doi:10.4049/jimmunol.1300171
83. Santi A, Caselli A, Ranaldi F, Paoli P, Mugnaioni C, Michelucci E, Cirri P (2015) Cancer associated fibroblasts transfer lipids and proteins to cancer cells through cargo vesicles supporting tumor growth. Biochim Biophys Acta 1853:3211–3223. doi:10.1016/j.bbamcr.2015.09.013
84. Reynés G, Vila V, Fleitas T, Reganon E, Font de Mora J, Jordá M, Martínez-Sales V (2013) Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value. PLoS ONE. doi:10.1371/journal.pone.0069034
85. Fleitas T, Martínez-Sales V, Vila V, Reganon E, Mesado D, Martín M, Gómez-Codina J, Montalar J, Reynés G (2012) Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer. PLoS ONE. doi:10.1371/journal.pone.0047365
86. Krishnan SR, Luk F, Brown RD, Suen H, Kwan Y, Bebawy M (2016) Isolation of human CD138(+) microparticles from the plasma of patients with multiple myeloma. Neoplasia 18:25–32. doi:10.1016/j.neo.2015.11.011
87. Liebhardt S, Ditsch N, Nieuwland R, Rank A, Jeschke U, Von Koch F, Friese K, Toth B (2010) CEA-, Her2/neu-, BCRP- and Hsp27-positive microparticles in breast cancer patients. Anticancer Res 30:1707–1712
88. Tavoosidana G, Ronquist G, Darmanis S, Yan J, Carlsson L, Wu D, Conze T, Ek P, Semjonow A, Eltze E, Larsson A, Landegren UD, Kamali-Moghaddam M (2011) Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer. Proc Natl Acad Sci USA 108:8809–8814. doi:10.1073/pnas.1019330108
89. Mege D, Panicot-Dubois L, Ouaissi M, Robert S, Sielezneff I, Sastre B, Dignat-George F, Dubois C (2016) The origin and concentration of circulating microparticles differ according to cancer type and evolution: a prospective single-center study. Int J Cancer 138:939–948. doi:10.1002/ijc.29837
90. Thaler J, Ay C, Mackman N, Metz-Schimmerl S, Stift J, Kaider A, Müllauer L, Gnant M, Scheithauer W, Pabinger I (2013) Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features. Eur J Clin Invest 43:277–285. doi:10.1111/eci.12042
91. Böing AN, Van der Pol E, Grootemaat AE, Coumans FAW, Sturk A, Nieuwland R (2014) Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles. doi:10.3402/jev.v3.23430
92. Rupert DL, Claudio V, Lässer C, Bally M (2016) Methods for the physical characterization and quantification of extracellular vesicles in biological samples. Biochim Biophys Acta. doi:10.1016/j.bbagen.2016.07.028
93. Jorfi S, Ansa-Addo EA, Kholia S, Stratton S, Valley S, Lange S, Inal J (2015) Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo. Sci Rep 5:1–13. doi:10.1038/srep13006
94. De Souza PS, Faccion RS, Bernardo PS, Maia RC (2016) Membrane microparticles: shedding new light into cancer cell communication. J Cancer Res Clin Oncol 142:1395–1406. doi:10.1007/s00432-015-2029-8
95. Bebawy M, Combes V, Lee E, Jaiswal R, Gong J, Bonhoure A, Grau GE (2009) Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia 23:1643–1649. doi:10.1038/leu.2009.76
96. De Souza PS, Cruz AL, Viola JP, Maia RC (2015) Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type. Cancer Sci 106:60–68. doi:10.1111/cas.12566
97. Lu JF, Luk G, Gong J, Jaiswal R, Grau GE, Bebawy M (2013) Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways. Pharmacol Res 76:77–83. doi:10.1016/j.phrs.2013.07.009
98. Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR (2003) Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res 63:4331–4337
99. Kholia S, Jorfi S, Thompson PR, Causey CP, Nicholas AP, Inal JM, Lange S (2015) A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy. J Extracell Vesicles 4:1–16. doi:10.3402/jev.v4.26192
100. Ansa-Addo EA, Lange S, Stratton D, Antwi-Baffour S, Cestari I, Ramirez MI, McCrossan MV, Inal JM (2010) Human plasma membrane-derived vesicles halt proliferation and induce differentiation of THP-1 acute monocytic leukemia cells. J Immunol 185:5236–5246. doi:10.4049/jimmunol.1001656
101. Tang K, Zhang Y, Zhang H, Xu P, Liu J, Ma J, Lv M, Li D, Katirai F, Shen GX, Zhang G, Feng ZH, Ye D, Huang B (2012) Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nat Commun 3:1–11. doi:10.1038/ncomms2282
102. Yu KF, Zhang WQ, Luo LM, Song P, Li D, Du R, Ren W, Huang D, Lu WL, Zhang X, Zhang Q (2013) The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation. Int J Nanomed 8:2473–2485. doi:10.2147/IJN.S46962
103. Latagliata R, Breccia M, Fazi P, Iacobelli S, Martinelli G, Di Raimondo F, Sborgia M, Fabbiano F, Pirrotta MT, Zaccaria A, Amadori S, Caramatti C, Falzetti F, Candoni A, Mattei D, Morselli M, Alimena G, Vignetti M, Baccarani M, Mandelli F (2008) Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia. Br J Haematol 143:681–689. doi:10.1111/j.1365-2141.2008.07400.x
104. Kaspers GJ, Zimmermann M, Reinhardt D, Gibson BE, Tamminga RY, Aleinikova O, Armendariz H, Dworzak M, Ha SY, Hasle H, Hovi L, Maschan A, Bertrand Y, Leverger GG, Razzouk BI, Rizzari C, Smisek P, Smith O, Stark B, Creutzig U (2013) Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group. J Clin Oncol 31:599–607. doi:10.1200/JCO.2012.43.7384
105. Zhang H, Tang K, Zhang Y, Ma R, Ma J, Li Y, Luo S, Liang X, Ji T, Gu Z, Lu J, He W, Cao X, Wan Y, Huang B (2015) Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS/STING signaling. Cancer Immunol Res 3:196–205. doi:10.1158/2326-6066.CIR-14-0177
106. Zhang H, Huang B (2015) Tumor cell-derived microparticles: a new form of cancer vaccine. Oncoimmunology. doi:10.1080/2162402X.2015.1017704
107. Ran L, Tan X, Li Y, Zhang H, Ma R, Ji T, Dong W, Tong T, Liu Y, Chen D, Yin X, Liang X, Tang K, Ma J, Zhang Y, Cao X, Hu Z, Qin X, Huang B (2016) Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy. Biomaterials 89:56–66. doi:10.1016/j.biomaterials.2016.02.025
108. Akao Y, Iio A, Itoh T, Noguchi S, Itoh Y, Ohtsuki Y, Naoe T (2011) Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol Ther 19:395–399. doi:10.1038/mt.2010.254
109. Kim HK, Song KS, Park YS, Kang YH, Lee YJ, Lee KR, Kim HK, Ryu KW, Bae JM, Kim S (2003) Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 39:184–191. doi:10.1016/S0959-8049(02)00596-8
110. Ma G, Liu F, Lv L, Gao Y, Su Y (2013) Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia. Ann Hematol 92:645–652. doi:10.1007/s00277-013-1676-6